April 25, 2024

Heal Me Healthy

The Trusted Source For Health

Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD

3 min read
Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD

SAN DIEGO, CA, Aug. 11, 2022 (World NEWSWIRE) — by using NewMediaWire – Professional medical Cannabis, Inc. (OTC: MJNA) (the “Company”), the very first-at any time publicly traded hashish firm in the United States that launched the world’s initial-at any time hashish-derived nutraceutical items, models, and source chain, announced now its pharmaceutical subsidiary, HM Pharma, has submitted a merchandise dossier for its cannabidiol (CBD) goods just after acquiring Sanitary Authorization from ANVISA, Brazil’s Health Regulatory Agency. 

Beneath ANVISA Normative 327/2019, this registration lets providers these as HM Pharma to bulk import raw extracts, isolated cannabinoids or completed products as perfectly as manufacture and distribute cannabis items to pharmacies in Brazil. 

“This is a massive accomplishment for our business and terrific news for the citizens of Brazil,” said Matheus Patelli, Handling Director of HM Pharma. “Submitting our dossier is the final step to registering our item as a pharmaceutical solution in Brazil enabling our company to market our items in pharmacies. We hope to offer another selection to entry CBD for all those in require.”

Medical Cannabis, Inc. subsidiary HempMeds® Brasil was the first company to legally import products to Brazil in 2015 making use of Brazil’s Compassionate Use guidelines. The compassionate use market in Brazil is flourishing and it will carry on to coexist with the medical market. HempMeds® Brasil, which is at the moment expanding 75{b574a629d83ad7698d9c0ca2d3a10ad895e8e51aa97c347fc42e9508f0e4325d} quicker than the all round Brazilian CBD market, and is the leading organization in Brazil’s hashish field, will keep on to run beneath the compassionate use design, though HM Pharma will operate below ANVISA Normative 327/2019.

“It’s remarkable to see continued development and regulatory development for our enterprise in Brazil,” explained Health care Cannabis, Inc. CEO Blake Schroeder. “We are optimistic about our extraordinary ahead momentum into the pharmaceutical area, and we search ahead to sharing much more interesting updates on our new gross sales channels in the near upcoming.”

About Clinical Cannabis, Inc.

We are a organization of firsts®. Health-related Cannabis, Inc. (MJNA) is a cannabis business with 3 distinct small business units in the non-psychoactive cannabinoid place: a international portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds® a pioneer in sourcing the maximum-high quality legal non-psychoactive hashish merchandise derived from industrial hemp and a cannabinoid-primarily based scientific investigate and botanical drug improvement sector led by its pharmaceutical financial investment firms and partners together with AXIM® Biotechnologies, Inc. and Neuropathix. Health care Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the to start with business to acquire historic import permits for CBD solutions from the governments of Brazil, Mexico, Argentina, and Paraguay and is a chief in the improvement of intercontinental marketplaces. The company’s flagship merchandise Authentic Scientific Hemp Oil has been utilised in various thriving medical experiments all through Mexico and Brazil to comprehend its protection and efficacy.

Professional medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information and facts is offered at OTCMarkets.com or by visitingwww.medicalmarijuanainc.com. To see Medical Cannabis, Inc.’s corporate online video, click on below.

Forward-Wanting DISCLAIMER

This push release may possibly have sure forward-on the lookout statements and facts, as described in just the indicating of Area 27A of the Securities Act of 1933 and Area 21E of the Securities Exchange Act of 1934, and is issue to the Safe Harbor created by those sections. This materials consists of statements about anticipated future functions and/or financial outcomes that are forward-wanting in nature and issue to pitfalls and uncertainties. This kind of ahead-on the lookout statements by definition require dangers, uncertainties and other things, which may perhaps bring about the real final results, performance or achievements of Healthcare Marijuana, Inc. to be materially distinct from the statements manufactured herein.

Food stuff AND DRUG ADMINISTRATION (Food and drug administration) DISCLOSURE

These statements have not been evaluated by the Foods and Drug Administration. This product is not meant to diagnose, handle, remedy, or prevent any ailment.


Medical Cannabis, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

Make contact with:
Community Relations Get in touch with:
Kyle Porter
CMW Media
P. 858-221-8001
[email protected]

Trader Relations Get hold of:
P. (858) 283-4016
[email protected]

Copyright ©heelsme.com All rights reserved. | Newsphere by AF themes.